newsfilter
← Latest News
GlobeNewswire·

Boundless Bio Announces Departure of Chief Financial Officer

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with